Melanie Dias, Z. Shaida, N. Haloob, Claire Hopkins
Olfactory dysfunction is one of the most recognized symptoms of COVID‐19, significantly impacting quality of life, particularly in cases where recovery is prolonged. This review aims to explore patterns of olfactory recovery post‐COVID‐19 infection, with particular focus on delayed recovery.Published literature in the English language, including senior author's own work, online and social media platforms, and patients' anecdotal reports.A comprehensive review of the literature was undertaken by the authors with guidance from the senior author with expertise in the field of olfaction.Based on self‐report, an estimated 95% of patients recover their olfactory function within 6 months post‐COVID‐19 infection. However, psychophysical testing detects higher rates of persistent olfactory dysfunction. Recovery has been found to continue for at least 2 years postinfection; negative prognostic indicators include severe olfactory loss in the acute phase, female sex, and older age. Variability in quantitative and qualitative disturbance in prolonged cases likely reflects both peripheral and central pathophysiological mechanisms. Limitations of many of the reviewed studies reflect lack of psychophysical testing and baseline olfactory assessment.Post‐COVID‐19 olfactory dysfunction remains a significant health and psychosocial burden. Emerging evidence is improving awareness and knowledge among clinicians to better support patients through their olfactory rehabilitation, with hope of recovery after several months or years. Further research is needed to better understand the underlying pathogenesis of delayed recovery, identify at risk individuals earlier in the disease course, and develop therapeutic targets.
{"title":"Recovery rates and long‐term olfactory dysfunction following COVID‐19 infection","authors":"Melanie Dias, Z. Shaida, N. Haloob, Claire Hopkins","doi":"10.1002/wjo2.163","DOIUrl":"https://doi.org/10.1002/wjo2.163","url":null,"abstract":"Olfactory dysfunction is one of the most recognized symptoms of COVID‐19, significantly impacting quality of life, particularly in cases where recovery is prolonged. This review aims to explore patterns of olfactory recovery post‐COVID‐19 infection, with particular focus on delayed recovery.Published literature in the English language, including senior author's own work, online and social media platforms, and patients' anecdotal reports.A comprehensive review of the literature was undertaken by the authors with guidance from the senior author with expertise in the field of olfaction.Based on self‐report, an estimated 95% of patients recover their olfactory function within 6 months post‐COVID‐19 infection. However, psychophysical testing detects higher rates of persistent olfactory dysfunction. Recovery has been found to continue for at least 2 years postinfection; negative prognostic indicators include severe olfactory loss in the acute phase, female sex, and older age. Variability in quantitative and qualitative disturbance in prolonged cases likely reflects both peripheral and central pathophysiological mechanisms. Limitations of many of the reviewed studies reflect lack of psychophysical testing and baseline olfactory assessment.Post‐COVID‐19 olfactory dysfunction remains a significant health and psychosocial burden. Emerging evidence is improving awareness and knowledge among clinicians to better support patients through their olfactory rehabilitation, with hope of recovery after several months or years. Further research is needed to better understand the underlying pathogenesis of delayed recovery, identify at risk individuals earlier in the disease course, and develop therapeutic targets.","PeriodicalId":510563,"journal":{"name":"World Journal of Otorhinolaryngology - Head and Neck Surgery","volume":"55 32","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140230936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Renad M Alsolamy, Abdulaziz K. Alaraifi, Yazeed Aloqaili
Epley maneuver is the most effective treatment for benign paroxysmal positional vertigo (BPPV). Betahistine has been shown to be effective in treating BPPV. This systematic review aims to compare the effectiveness of Epley maneuver with betahistine to Epley maneuver alone in reducing residual dizziness in BPPV.Medline, Embase, and CENTRAL.We included randomized controlled trials (RCTs) that compared Epley maneuver with betahistine to Epley maneuver alone for treating BPPV. We evaluated the effectiveness of this intervention using Dizziness Handicap Inventory (DHI), Visual Analog Scale (VAS) for vertigo, and provocation maneuvers. We used the standardized mean difference (SMD) for continuous outcomes and the odds ratio (OR) for the dichotomous outcomes.A total of eight RCTs that enrolled 516 participants were deemed eligible. Administration of betahistine with Epley maneuver showed no clinically significant difference over Epley maneuver alone in DHI score (SMD: −0.11, 95% confidence interval [CI], −0.57 to 0.34, p = 0.63, I2 = 79%), VAS scores (SMD: −0.57, 95% CI, −1.57 to 0.43, p = 0.26, I2 = 89%), or on provocation maneuvers (OR: 1.84, 95% CI, 0.92 to 3.68, p = 0.08, I2 = 0%) after 1 week of betahistine administration. However, participants who received betahistine combined with Epley maneuver showed a statistically significant reduction in VAS scores after 4 weeks of betahistine administration (SMD: −0.89, 95% CI, −1.30 to −0.49, p < 0.0001, I2 = 33%).Combining betahistine with Epley maneuver could improve the outcomes of BPPV in the long term. However, clinical trials with longer follow‐up periods are needed to unravel its efficacy.
{"title":"Effectiveness of betahistine as an add‐on therapy to epley maneuver for benign paroxysmal positional vertigo: A systematic review and meta‐analysis","authors":"Renad M Alsolamy, Abdulaziz K. Alaraifi, Yazeed Aloqaili","doi":"10.1002/wjo2.161","DOIUrl":"https://doi.org/10.1002/wjo2.161","url":null,"abstract":"Epley maneuver is the most effective treatment for benign paroxysmal positional vertigo (BPPV). Betahistine has been shown to be effective in treating BPPV. This systematic review aims to compare the effectiveness of Epley maneuver with betahistine to Epley maneuver alone in reducing residual dizziness in BPPV.Medline, Embase, and CENTRAL.We included randomized controlled trials (RCTs) that compared Epley maneuver with betahistine to Epley maneuver alone for treating BPPV. We evaluated the effectiveness of this intervention using Dizziness Handicap Inventory (DHI), Visual Analog Scale (VAS) for vertigo, and provocation maneuvers. We used the standardized mean difference (SMD) for continuous outcomes and the odds ratio (OR) for the dichotomous outcomes.A total of eight RCTs that enrolled 516 participants were deemed eligible. Administration of betahistine with Epley maneuver showed no clinically significant difference over Epley maneuver alone in DHI score (SMD: −0.11, 95% confidence interval [CI], −0.57 to 0.34, p = 0.63, I2 = 79%), VAS scores (SMD: −0.57, 95% CI, −1.57 to 0.43, p = 0.26, I2 = 89%), or on provocation maneuvers (OR: 1.84, 95% CI, 0.92 to 3.68, p = 0.08, I2 = 0%) after 1 week of betahistine administration. However, participants who received betahistine combined with Epley maneuver showed a statistically significant reduction in VAS scores after 4 weeks of betahistine administration (SMD: −0.89, 95% CI, −1.30 to −0.49, p < 0.0001, I2 = 33%).Combining betahistine with Epley maneuver could improve the outcomes of BPPV in the long term. However, clinical trials with longer follow‐up periods are needed to unravel its efficacy.","PeriodicalId":510563,"journal":{"name":"World Journal of Otorhinolaryngology - Head and Neck Surgery","volume":"41 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140231531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Emad A. Magdy, Mahmoud Seif-Elnasr, Omneya Gamaleldin, Mohamed K. Taha, Mohamed F. Fathalla
Sialendoscopy has become the standard treatment for sialolithiasis; however, larger submandibular calculi may require an incisional technique. This study describes and evaluates an intraoral microscopic‐assisted sialolithotomy (IMAS) as a refined submandibular stone extraction technique.Retrospective case series of 64 submandibular IMAS procedures operated at a tertiary university center and private hospital from 2015 to 2021 were evaluated. Preoperative radiological assessment included noncontrast computed tomography scan ± magnetic resonance sialography. Stone characteristics (side, number, size, and location), operative findings, complications, and postoperative follow‐up were reviewed. Success was defined as successful intraoral stone extraction with no symptoms or stone recurrence for at least 12 months postoperatively.The study included 43 males and 19 females, mean age 38 ± 12 years. Two patients had bilateral stones. All but one operated gland had stones extracted (98.4%), however the true success was 93.8% (60/64) as three patients had recurrent/residual stones within a year. Biggest stone longest diameter was 9.8 ± 4.6 mm (range, 5–30 mm). Hilar and intraglandular stone locations were 73.4% and 6.3%, respectively. Median operative time was 55 min. Adjunctive sialendoscopy was performed in 42.2%. Its use is significantly correlated with having ˃3 stones (mean 3.4 vs. 1.2 stones) [P < 0.001, 95% confidence interval: −3.19 to −1.25]. Minor complications included temporary lingual paresthesia (7.8%) and postoperative ranula (1.6%).Submandibular IMAS is a highly effective safe technique for stones (≥5 mm). The improved microscopic visualization, illumination and magnification allows addressing all stone locations including intraglandular calculi and enables better lingual nerve identification and preservation.
{"title":"Intraoral microscopic‐assisted sialolithotomy for management of medium‐large submandibular sialolithiasis: A refined technique","authors":"Emad A. Magdy, Mahmoud Seif-Elnasr, Omneya Gamaleldin, Mohamed K. Taha, Mohamed F. Fathalla","doi":"10.1002/wjo2.153","DOIUrl":"https://doi.org/10.1002/wjo2.153","url":null,"abstract":"Sialendoscopy has become the standard treatment for sialolithiasis; however, larger submandibular calculi may require an incisional technique. This study describes and evaluates an intraoral microscopic‐assisted sialolithotomy (IMAS) as a refined submandibular stone extraction technique.Retrospective case series of 64 submandibular IMAS procedures operated at a tertiary university center and private hospital from 2015 to 2021 were evaluated. Preoperative radiological assessment included noncontrast computed tomography scan ± magnetic resonance sialography. Stone characteristics (side, number, size, and location), operative findings, complications, and postoperative follow‐up were reviewed. Success was defined as successful intraoral stone extraction with no symptoms or stone recurrence for at least 12 months postoperatively.The study included 43 males and 19 females, mean age 38 ± 12 years. Two patients had bilateral stones. All but one operated gland had stones extracted (98.4%), however the true success was 93.8% (60/64) as three patients had recurrent/residual stones within a year. Biggest stone longest diameter was 9.8 ± 4.6 mm (range, 5–30 mm). Hilar and intraglandular stone locations were 73.4% and 6.3%, respectively. Median operative time was 55 min. Adjunctive sialendoscopy was performed in 42.2%. Its use is significantly correlated with having ˃3 stones (mean 3.4 vs. 1.2 stones) [P < 0.001, 95% confidence interval: −3.19 to −1.25]. Minor complications included temporary lingual paresthesia (7.8%) and postoperative ranula (1.6%).Submandibular IMAS is a highly effective safe technique for stones (≥5 mm). The improved microscopic visualization, illumination and magnification allows addressing all stone locations including intraglandular calculi and enables better lingual nerve identification and preservation.","PeriodicalId":510563,"journal":{"name":"World Journal of Otorhinolaryngology - Head and Neck Surgery","volume":"18 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140266165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Member List of the Second Editorial Board of World Journal of Otorhinolaryngology‐Head and Neck Surgery","authors":"","doi":"10.1002/wjo2.171","DOIUrl":"https://doi.org/10.1002/wjo2.171","url":null,"abstract":"","PeriodicalId":510563,"journal":{"name":"World Journal of Otorhinolaryngology - Head and Neck Surgery","volume":"3 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140406656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vishav Yadav, Sanjeev Bhagat, Khushboo Goel, R. Sibia, D. Sharma, T. Sidhu, Saivi Rajdev, Ankita Aggarwal
The objective of this study was to study the various outcomes among coronavirus disease 2019 (COVID‐19)‐associated mucormycosis (CAM) in terms of morbidity and mortality.A prospective study was done on 107 patients (60 male, 47 female) in the Department of Otolaryngology and Head and Neck Surgery, Government Medical College, Patiala, India, diagnosed with CAM from April 2021 to August 2021. The patients were managed both medically and surgically. The follow‐up was done up to 2 years to assess the various outcomes.Out of 107 patients, short‐term (3 months) survival was 68.22%, and long‐term (2 years) survival was 52.34%. Overall mortality was 47.66%, with short‐term mortality of 31.77% and long‐term mortality of 15.89%. Eye loss was seen in 17 patients, residual ophthalmoplegia in 12, palatal loss in 15, depression in 56, cerebrospinal fluid rhinorrhea in two, and recurrence in two patients.In conclusion, despite early management and successful initial outcome, the patients are still haunted by the after‐effects of CAM like residual morbidity in terms of eye and palate loss, ophthalmoplegia, and depression. Delayed mortality has also been noticed over 2 years of follow‐up.
{"title":"Outcomes of COVID‐19‐associated mucormycosis epidemic in India: A prospective 2‐year follow‐up study","authors":"Vishav Yadav, Sanjeev Bhagat, Khushboo Goel, R. Sibia, D. Sharma, T. Sidhu, Saivi Rajdev, Ankita Aggarwal","doi":"10.1002/wjo2.162","DOIUrl":"https://doi.org/10.1002/wjo2.162","url":null,"abstract":"The objective of this study was to study the various outcomes among coronavirus disease 2019 (COVID‐19)‐associated mucormycosis (CAM) in terms of morbidity and mortality.A prospective study was done on 107 patients (60 male, 47 female) in the Department of Otolaryngology and Head and Neck Surgery, Government Medical College, Patiala, India, diagnosed with CAM from April 2021 to August 2021. The patients were managed both medically and surgically. The follow‐up was done up to 2 years to assess the various outcomes.Out of 107 patients, short‐term (3 months) survival was 68.22%, and long‐term (2 years) survival was 52.34%. Overall mortality was 47.66%, with short‐term mortality of 31.77% and long‐term mortality of 15.89%. Eye loss was seen in 17 patients, residual ophthalmoplegia in 12, palatal loss in 15, depression in 56, cerebrospinal fluid rhinorrhea in two, and recurrence in two patients.In conclusion, despite early management and successful initial outcome, the patients are still haunted by the after‐effects of CAM like residual morbidity in terms of eye and palate loss, ophthalmoplegia, and depression. Delayed mortality has also been noticed over 2 years of follow‐up.","PeriodicalId":510563,"journal":{"name":"World Journal of Otorhinolaryngology - Head and Neck Surgery","volume":"68 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140430369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nader Wehbi, Claire Gleadhill, David Ahmadian, Jonathan R. Skirko, Helena T. Yip
Subglottic stenosis (SGS) is commonly treated with endoscopic dilations or tracheal resection. Since office‐based serial intralesional steroid injections (SILSI) were first reported in 2017, they have been established as an effective, less invasive treatment alternative or adjunct. The aim of this study is to add to the literature investigating the efficacy of office‐based SILSIs for idiopathic and post‐intubation SGS patients, specifically studying surgery‐free intervals (SFIs) and discussing our experience with SILSI treatment order and stenosis grade.This study is a retrospective case series of 14 patients with subglottic stenosis treated with in‐office serial intralesional steroid injections as a primary or adjuvant treatment from 2018 to 2022 in an academic tertiary care center.Of seven patients with calculable SFI, a mean SFI increase of 481.28 days was observed following SILSI treatment (p = 0.042). Ten patients in our cohort presented with idiopathic or post‐intubation grade 2 SGS and were managed successfully with a combination of endoscopic dilation and SILSI. Two patients with post‐intubation grade 1 SGS were managed successfully with SILSI as their primary treatment. Two patients with post‐intubation grade 3 SGS required a tracheal resection and did not benefit from SILSI.We have found that SFI significantly increased following SILSI initiation. Although statistical power was limited given the small sample size, our findings suggest that SILSI may be an effective primary treatment in low‐grade stenosis. SILSI as an adjuvant to endoscopic dilation may be most effective in intermediate‐grade stenosis. SILSI may not be effective in high‐grade stenosis patients who failed prior endoscopic treatment.
{"title":"In‐office serial intralesional steroid injection for subglottic stenosis: Case series of 14 patients with multiple etiologies","authors":"Nader Wehbi, Claire Gleadhill, David Ahmadian, Jonathan R. Skirko, Helena T. Yip","doi":"10.1002/wjo2.159","DOIUrl":"https://doi.org/10.1002/wjo2.159","url":null,"abstract":"Subglottic stenosis (SGS) is commonly treated with endoscopic dilations or tracheal resection. Since office‐based serial intralesional steroid injections (SILSI) were first reported in 2017, they have been established as an effective, less invasive treatment alternative or adjunct. The aim of this study is to add to the literature investigating the efficacy of office‐based SILSIs for idiopathic and post‐intubation SGS patients, specifically studying surgery‐free intervals (SFIs) and discussing our experience with SILSI treatment order and stenosis grade.This study is a retrospective case series of 14 patients with subglottic stenosis treated with in‐office serial intralesional steroid injections as a primary or adjuvant treatment from 2018 to 2022 in an academic tertiary care center.Of seven patients with calculable SFI, a mean SFI increase of 481.28 days was observed following SILSI treatment (p = 0.042). Ten patients in our cohort presented with idiopathic or post‐intubation grade 2 SGS and were managed successfully with a combination of endoscopic dilation and SILSI. Two patients with post‐intubation grade 1 SGS were managed successfully with SILSI as their primary treatment. Two patients with post‐intubation grade 3 SGS required a tracheal resection and did not benefit from SILSI.We have found that SFI significantly increased following SILSI initiation. Although statistical power was limited given the small sample size, our findings suggest that SILSI may be an effective primary treatment in low‐grade stenosis. SILSI as an adjuvant to endoscopic dilation may be most effective in intermediate‐grade stenosis. SILSI may not be effective in high‐grade stenosis patients who failed prior endoscopic treatment.","PeriodicalId":510563,"journal":{"name":"World Journal of Otorhinolaryngology - Head and Neck Surgery","volume":"305 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139852162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nader Wehbi, Claire Gleadhill, David Ahmadian, Jonathan R. Skirko, Helena T. Yip
Subglottic stenosis (SGS) is commonly treated with endoscopic dilations or tracheal resection. Since office‐based serial intralesional steroid injections (SILSI) were first reported in 2017, they have been established as an effective, less invasive treatment alternative or adjunct. The aim of this study is to add to the literature investigating the efficacy of office‐based SILSIs for idiopathic and post‐intubation SGS patients, specifically studying surgery‐free intervals (SFIs) and discussing our experience with SILSI treatment order and stenosis grade.This study is a retrospective case series of 14 patients with subglottic stenosis treated with in‐office serial intralesional steroid injections as a primary or adjuvant treatment from 2018 to 2022 in an academic tertiary care center.Of seven patients with calculable SFI, a mean SFI increase of 481.28 days was observed following SILSI treatment (p = 0.042). Ten patients in our cohort presented with idiopathic or post‐intubation grade 2 SGS and were managed successfully with a combination of endoscopic dilation and SILSI. Two patients with post‐intubation grade 1 SGS were managed successfully with SILSI as their primary treatment. Two patients with post‐intubation grade 3 SGS required a tracheal resection and did not benefit from SILSI.We have found that SFI significantly increased following SILSI initiation. Although statistical power was limited given the small sample size, our findings suggest that SILSI may be an effective primary treatment in low‐grade stenosis. SILSI as an adjuvant to endoscopic dilation may be most effective in intermediate‐grade stenosis. SILSI may not be effective in high‐grade stenosis patients who failed prior endoscopic treatment.
{"title":"In‐office serial intralesional steroid injection for subglottic stenosis: Case series of 14 patients with multiple etiologies","authors":"Nader Wehbi, Claire Gleadhill, David Ahmadian, Jonathan R. Skirko, Helena T. Yip","doi":"10.1002/wjo2.159","DOIUrl":"https://doi.org/10.1002/wjo2.159","url":null,"abstract":"Subglottic stenosis (SGS) is commonly treated with endoscopic dilations or tracheal resection. Since office‐based serial intralesional steroid injections (SILSI) were first reported in 2017, they have been established as an effective, less invasive treatment alternative or adjunct. The aim of this study is to add to the literature investigating the efficacy of office‐based SILSIs for idiopathic and post‐intubation SGS patients, specifically studying surgery‐free intervals (SFIs) and discussing our experience with SILSI treatment order and stenosis grade.This study is a retrospective case series of 14 patients with subglottic stenosis treated with in‐office serial intralesional steroid injections as a primary or adjuvant treatment from 2018 to 2022 in an academic tertiary care center.Of seven patients with calculable SFI, a mean SFI increase of 481.28 days was observed following SILSI treatment (p = 0.042). Ten patients in our cohort presented with idiopathic or post‐intubation grade 2 SGS and were managed successfully with a combination of endoscopic dilation and SILSI. Two patients with post‐intubation grade 1 SGS were managed successfully with SILSI as their primary treatment. Two patients with post‐intubation grade 3 SGS required a tracheal resection and did not benefit from SILSI.We have found that SFI significantly increased following SILSI initiation. Although statistical power was limited given the small sample size, our findings suggest that SILSI may be an effective primary treatment in low‐grade stenosis. SILSI as an adjuvant to endoscopic dilation may be most effective in intermediate‐grade stenosis. SILSI may not be effective in high‐grade stenosis patients who failed prior endoscopic treatment.","PeriodicalId":510563,"journal":{"name":"World Journal of Otorhinolaryngology - Head and Neck Surgery","volume":" 23","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139792524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Although neck dissection has evolved to become an integral part of the surgical armamentarium for managing head and neck cancers, the manner in which the procedure has reached its present state is worth revisiting.Published original articles, reviews, clinical practice guidelines, and consensus statements related to the basis, indication, and classification of the neck dissection.This review discusses some of the critical milestones before and after the description of the procedure of neck dissection by George Crile Sr. in 1905, which eventually played a role in the evolution of this commonly performed oncosurgical procedure.Several large observational studies of the twentieth century and multicentric randomized trials at the turn of the twenty‐first century have shaped neck dissection into a safe and reliable oncosurgical procedure.From being a radical surgery that was done mostly in large nodal diseases for curative or palliative purposes to becoming a simple procedure that is carried out even in node‐negative cases of head and neck cancers for prognostic purposes, the procedure of neck dissection has come a long way and continues to evolve.
{"title":"Historical milestones in the evolution of the procedure of neck dissection","authors":"K. Devaraja","doi":"10.1002/wjo2.152","DOIUrl":"https://doi.org/10.1002/wjo2.152","url":null,"abstract":"Although neck dissection has evolved to become an integral part of the surgical armamentarium for managing head and neck cancers, the manner in which the procedure has reached its present state is worth revisiting.Published original articles, reviews, clinical practice guidelines, and consensus statements related to the basis, indication, and classification of the neck dissection.This review discusses some of the critical milestones before and after the description of the procedure of neck dissection by George Crile Sr. in 1905, which eventually played a role in the evolution of this commonly performed oncosurgical procedure.Several large observational studies of the twentieth century and multicentric randomized trials at the turn of the twenty‐first century have shaped neck dissection into a safe and reliable oncosurgical procedure.From being a radical surgery that was done mostly in large nodal diseases for curative or palliative purposes to becoming a simple procedure that is carried out even in node‐negative cases of head and neck cancers for prognostic purposes, the procedure of neck dissection has come a long way and continues to evolve.","PeriodicalId":510563,"journal":{"name":"World Journal of Otorhinolaryngology - Head and Neck Surgery","volume":"97 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139802153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Although neck dissection has evolved to become an integral part of the surgical armamentarium for managing head and neck cancers, the manner in which the procedure has reached its present state is worth revisiting.Published original articles, reviews, clinical practice guidelines, and consensus statements related to the basis, indication, and classification of the neck dissection.This review discusses some of the critical milestones before and after the description of the procedure of neck dissection by George Crile Sr. in 1905, which eventually played a role in the evolution of this commonly performed oncosurgical procedure.Several large observational studies of the twentieth century and multicentric randomized trials at the turn of the twenty‐first century have shaped neck dissection into a safe and reliable oncosurgical procedure.From being a radical surgery that was done mostly in large nodal diseases for curative or palliative purposes to becoming a simple procedure that is carried out even in node‐negative cases of head and neck cancers for prognostic purposes, the procedure of neck dissection has come a long way and continues to evolve.
{"title":"Historical milestones in the evolution of the procedure of neck dissection","authors":"K. Devaraja","doi":"10.1002/wjo2.152","DOIUrl":"https://doi.org/10.1002/wjo2.152","url":null,"abstract":"Although neck dissection has evolved to become an integral part of the surgical armamentarium for managing head and neck cancers, the manner in which the procedure has reached its present state is worth revisiting.Published original articles, reviews, clinical practice guidelines, and consensus statements related to the basis, indication, and classification of the neck dissection.This review discusses some of the critical milestones before and after the description of the procedure of neck dissection by George Crile Sr. in 1905, which eventually played a role in the evolution of this commonly performed oncosurgical procedure.Several large observational studies of the twentieth century and multicentric randomized trials at the turn of the twenty‐first century have shaped neck dissection into a safe and reliable oncosurgical procedure.From being a radical surgery that was done mostly in large nodal diseases for curative or palliative purposes to becoming a simple procedure that is carried out even in node‐negative cases of head and neck cancers for prognostic purposes, the procedure of neck dissection has come a long way and continues to evolve.","PeriodicalId":510563,"journal":{"name":"World Journal of Otorhinolaryngology - Head and Neck Surgery","volume":"3 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139862197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Venous vascular malformations of the parotid gland are very rare vascular tumors, especially among adults. This case report discusses the presentation and challenges of diagnosing a venous vascular malformation of the parotid gland in a patient with previous oncologic history. Our patient is a 45‐year‐old female with a history of breast cancer, meningioma, and secreting pituitary adenoma who presented with a malformation on magnetic resonance imaging, incidentally demonstrating a T2 intense mass in the superficial lobe of the right parotid gland. She was otherwise asymptomatic. Ultrasound‐guided fine needle aspiration was nondiagnostic. She underwent a right inferior superficial parotidectomy. Histologic section analysis demonstrated a well‐delineated vascular tumor made of large vascular spaces with thin walls surrounded by a parotid tissue consistent with a venous vascular malformation of the parotid gland. Venous vascular malformations are exceedingly rare, especially among adults. Ultrasound‐guided fine needle aspiration can be of limited value. Parotidectomy may be electively considered for diagnostic and therapeutic purposes.
{"title":"Venous vascular malformation of the parotid gland","authors":"Amir A. Hakimi, Eric L. Wu, Jonathan Giurintano","doi":"10.1002/wjo2.160","DOIUrl":"https://doi.org/10.1002/wjo2.160","url":null,"abstract":"Venous vascular malformations of the parotid gland are very rare vascular tumors, especially among adults. This case report discusses the presentation and challenges of diagnosing a venous vascular malformation of the parotid gland in a patient with previous oncologic history. Our patient is a 45‐year‐old female with a history of breast cancer, meningioma, and secreting pituitary adenoma who presented with a malformation on magnetic resonance imaging, incidentally demonstrating a T2 intense mass in the superficial lobe of the right parotid gland. She was otherwise asymptomatic. Ultrasound‐guided fine needle aspiration was nondiagnostic. She underwent a right inferior superficial parotidectomy. Histologic section analysis demonstrated a well‐delineated vascular tumor made of large vascular spaces with thin walls surrounded by a parotid tissue consistent with a venous vascular malformation of the parotid gland. Venous vascular malformations are exceedingly rare, especially among adults. Ultrasound‐guided fine needle aspiration can be of limited value. Parotidectomy may be electively considered for diagnostic and therapeutic purposes.","PeriodicalId":510563,"journal":{"name":"World Journal of Otorhinolaryngology - Head and Neck Surgery","volume":"45 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139865242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：